Gerber, D. E., Swanson, P., Lopez-Chavez, A., Wong, L., Dowlati, A., Pennell, N. A., . . . Baggstrom, M. Q. (2017). Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC. Lung Cancer.
Chicago Style citaatGerber, David E., et al. "Phase II Study of Olaratumab With Paclitaxel/carboplatin (P/C) or P/C Alone in Previously Untreated Advanced NSCLC." Lung Cancer 2017.
MLA citatieGerber, David E., et al. "Phase II Study of Olaratumab With Paclitaxel/carboplatin (P/C) or P/C Alone in Previously Untreated Advanced NSCLC." Lung Cancer 2017.
Let op: Deze citaties zijn niet altijd 100% accuraat.